Remission of Graves' Hyperthyroidism Predicted by Smooth Dec…
Established
65
Citations9
Refs2000
Year
Search Works
Work Details
- DOI 10.1089/thy.2000.10.891
- PMID https://pubmed.ncbi.nlm.nih.gov/11081255
- OpenAlex ID W2069592425
- Type Article
- Language EN
- Published 01 Oct 2000
- Volume 10 (10)
- Pages 891–896
- Source Thyroid
- Publisher Mary Ann Liebert, Inc.
- FWCI 1.26
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 08 Oct 2026
External Links
MENU
0
Remission of Graves' Hyperthyroidism Predicted by Smooth Decreases of Thyroid-Stimulating Antibody and Thyrotropin-Binding Inhibitor Immunoglobulin During Antithyroid Drug Treatment
Article 2000 EN
It is important to know whether a patient with Graves' disease will get into remission or not during antithyroid drug (ATD) treatment. Thyrotropin (TSH) receptor antibodies (TRAb) cause Graves' disease. Thyroid-stimulating antibody (TSAb) and TSH-binding inhibitor immunoglobulin (TBII) have been measured as TRAb to diagnose Graves' disease and to follow Graves' patients. Smooth decreases of TSAb a…
65
Citations
9
References
6
Authors
1.26
FWCI
Citations by Year
Last 12 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
6 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Nobuyuki Takasu | University of the Ryukyus (JP) | |
| 2 | Kei Yamashiro | — | — |
| 3 | lchiro Komiya | — | — |
| 4 | Yukio Ochi | — | |
| 5 | Yasusi Sato | — | — |
| 6 | Atuo Nagata | — | — |
Related Works
10Data: OpenAlex